Ignite Creation Date:
2024-05-06 @ 6:44 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05765773
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-03-13
First Post:
2023-02-13
Brief Title:
An Open Comparative Study of the Effectiveness and Incomparable Study of the Immunogenicity and Safety of the Vaccine CoviVac for Adults Aged 60 Years and Older
Sponsor:
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products
Organization:
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products
Study Overview
Official Title:
An Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine CoviVac for Adults Aged 60 Years and Older
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
An Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine CoviVac Produced by FSBSI Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products for Adults Aged 60 Years and Older
Detailed Description:
An open comparative multicenter prospective study with retrospective data
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None